English  |  正體中文  |  简体中文  |  Total items :2826576  
Visitors :  32005026    Online Users :  1054
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"pei jer chen"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 541-565 of 883  (36 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:34:04Z New insights into the evolutionary rate of hepatitis B virus at different biological scales Lin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; PEI-JER CHEN; Wang H.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:04Z Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:03Z Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota Chou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; Ni Y.-H.; Tseng H.-T.; Wu D.; Lu X.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:03Z Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma Li C.-L.; Yeh K.-H.; Liu W.-H.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:34:03Z Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection Song L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏 2021-07-03T03:34:02Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:02Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:02Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:01Z Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping Song L.-W.; Wang Y.-B.; Fang L.-L.; Wu Y.; Yang L.; Chen J.-Y.; Ge S.-X.; Zhang J.; Xiong Y.-Z.; Deng X.-M.; Min X.-P.; Zhang J.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏 2021-07-03T03:34:01Z Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system Liu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN; Chen C.-J.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:01Z Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model Chyuan I.-T.; Tsai H.-F.; Tzeng H.-T.; Sung C.-C.; Wu C.-S.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏 2021-07-03T03:34:00Z Contribution of adiponectin and its type 1 receptor to age-related hearing impairment Wu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; Yang W.-S.; PEI-JER CHEN; Liao W.-C.; Lee Y.L.; Liu T.-C.; Hsu C.-J.
臺大學術典藏 2021-07-03T03:34:00Z Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity Huang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:00Z Development of risk scoring system for stratifying population for hepatocellular carcinoma screening Hung Y.-C.; Lin C.-L.; Liu C.-J.; Hung H.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Chuang S.-C.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:59Z Gender disparity in chronic hepatitis B: Mechanisms of sex hormones Wang S.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:59Z Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-07-03T03:33:59Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; PEI-JER CHEN; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:58Z Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study Park J.-W.; Chen M.; Colombo M.; Roberts L.R.; Schwartz M.; PEI-JER CHEN; Kudo M.; Johnson P.; Wagner S.; Orsini L.S.; Sherman M.
臺大學術典藏 2021-07-03T03:33:58Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:58Z Treatment of liver cancer Liu C.-Y.; Chen K.-F.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:58Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:57Z Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S.
臺大學術典藏 2021-07-03T03:33:57Z Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1 Wang S.-H.; Yeh S.-H.; Shiau C.-W.; Chen K.-F.; Lin W.-H.; Tsai T.-F.; Teng Y.-C.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:57Z Use of HLA-B?58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏 2021-07-03T03:33:56Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.

Showing items 541-565 of 883  (36 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page